beractant
| Brand name | Survanta |
|---|---|
| Active ingredient | beractant |
| Strength | 200MG/8ML (25MG/ML) |
| Dosage form | Suspension |
| Route | Intratracheal |
| Modality | Biologic |
| FDA approval | July 1991 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.